PUBLIC CONTRACT · 2021
Interferao beta, natalizumab e peginterferao - 1o semestre
- Contract value
- €253,757.30
- Signed on
- 25 March 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7653754PUBLISHED SUBJECT
INTERFERAO BETA, NATALIZUMAB E PEGINTERFERAO - 1o SEMESTRE
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BIOGEN PORTUGAL SOCIEDADE FARMACEUTICA, UNIPESSOAL LDA · Tax ID 506415740
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €253,757.30
- Procedure base price
- €253,757.30
- Total effective price
- €210,691.56
- Publication date
- 11 May 2021
- Award date
- 26 January 2021
- Signing date
- 25 March 2021
- Performance period
- 97 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5067325
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.